Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis [Phase 2]
Phase 2 trial evaluating pomalidomide (CC-4047) plus dexamethasone in relapsed or refractory multiple myeloma and amyloidosis; results have …
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 update on non-myeloablative allogeneic stem cell transplantation using mis-matched family donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: PHA-739358 for the Treatment of Multiple Myeloma [Phase 2]
Phase 2 trial of PHA-739358 for multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 study of an allogeneic non-myeloablative stem cell transplant using matched family member donor cells purged with Campath (alemtuzum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. [Phase 1, Phase 2]
The study evaluated a conditioning regimen of melphalan and topotecan followed by autologous stem cell rescue in patients with multiple myel…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial of siltuximab (CNTO 328) in relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study assessing the efficacy and safety of siltuximab in relapsed or refractory…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma [Phase 2]
This Phase 2 trial evaluating the efficacy and safety of re-treatment with bortezomib in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]
Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]
A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marro…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone [Phase 3]
A phase 3 trial compared a triplet regimen of bortezomib, thalidomide, and dexamethasone to a bortezomib-dexamethasone doublet and to a bort…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study [Phase 3]
Phase 3 trial comparing pomalidomide plus low-dose dexamethasone to high-dose dexamethasone in refractory/relapsed multiple myeloma; study c…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma [Phase 1, Phase 2]
Results from a Phase 1/2 trial evaluating the combination of melphalan and panobinostat (LBH589) in patients with recurrent multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Exploratory Study on POL6326 in Stem Cell Mobilization [Phase 2]
An exploratory Phase 2 trial of POL6326 for stem cell mobilization in Multiple Myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated a combination therapy of pegylated liposomal doxorubicin, bortezomib, dexamethasone, and lenalidomide in relaps…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma [Phase 2]
Phase 2 study evaluating Plerixafor in combination with vinorelbine for stem cell mobilization in patients with multiple myeloma has complet…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma [Phase 1]
A Phase 1 study evaluated safety and feasibility of combining melphalan with palifermin in patients undergoing autologous peripheral stem ce…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy [Phase 2]
A Phase 2 trial evaluating lenalidomide (Revlimid) as induction and maintenance therapy for high-risk multiple myeloma has completed, with r…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Phase 3]
A Phase 3 clinical trial comparing denosumab with zoledronic acid for treating bone metastases in advanced cancer or multiple myeloma has co…